Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 10—October 2022
Research Letter

Cluster of Donor-Derived Cryptococcosis after Liver and Kidney Transplantation

Meng Sha1, Chuan Shen1, Ying TongComments to Author , and Qiang Xia
Author affiliation: Shanghai Jiao Tong University, Shanghai, China

Main Article


Postoperative cryptococcal antigen titer change and antifungal treatment regimen for transplant donor in cluster of donor-derived cryptococcosis, China

Postoperative day Cryptococcal antigen titer Treatment
30 >1:2,560 Amphotericin B lipid complex and 5‐flucytosine
60 >1:1,280 Oral fluconazole, 400 mg/d
90 >1:640 Oral fluconazole, 400 mg/d
120 1:640 Oral fluconazole, 400 mg/d
180 1:128 Oral fluconazole, 400 mg/d
270 1:128 Oral fluconazole, 400 mg/d
360 1:32 Oral fluconazole, 400 mg/d
450 Negative result Discontinued

Main Article

1These authors contributed equally to this article.

Page created: July 31, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.